Maureen Durkin is professor and chair of population health sciences and Waisman Center investigator at the University of Wisconsin-Madison. She received her undergraduate degree and Ph.D. in anthropology from the University of Wisconsin-Madison and her M.P.H. and Dr.P.H. degrees in epidemiology from Columbia University. Her research focuses on the epidemiology of neurodevelopmental disabilities and childhood injuries, both globally and within the United States. She has collaborated in the development of cross-cultural methods for epidemiologic studies of developmental disabilities and methods for surveillance of childhood injuries and disabilities. She has also directed international studies on the prevalence and causes of neurodevelopmental disabilities in low-income countries. Durkin is currently a principal investigator in the Autism and Developmental Disabilities Monitoring Network and other projects related to public health surveillance, epidemiology and care integration of autism and other developmental disabilities.
Maureen Durkin
Professor of population health sciences
University of Wisconsin-Madison
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.